Derek Hicks
Corporate Officer/Principal at INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Derek Hicks active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-12-19 | - |
Career history of Derek Hicks
Former positions of Derek Hicks
| Companies | Position | Start | End |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-08-31 | 2021-11-30 |
Training of Derek Hicks
| University of Connecticut | Graduate Degree |
| Kelley School of Business | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Derek Hicks
- Experience
